These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25050997)

  • 1. siRNA-mediated silencing of Wnt5a regulates inflammatory responses in atherosclerosis through the MAPK/NF-κB pathways.
    Yang L; Chu Y; Wang Y; Zhao X; Xu W; Zhang P; Liu X; Dong S; He W; Gao C
    Int J Mol Med; 2014 Oct; 34(4):1147-52. PubMed ID: 25050997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
    Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
    Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSRC1 overexpression attenuates atherosclerosis progression in apoE
    Guo K; Hu L; Xi D; Zhao J; Liu J; Luo T; Ma Y; Lai W; Guo Z
    J Mol Cell Cardiol; 2018 Mar; 116():69-80. PubMed ID: 29378206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin improves NF-κB-mediated inflammation and abates atherosclerosis progression in apolipoprotein E-deficient mice.
    Wang X; Chen Q; Pu H; Wei Q; Duan M; Zhang C; Jiang T; Shou X; Zhang J; Yang Y
    Lipids Health Dis; 2016 Feb; 15():33. PubMed ID: 26965176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR4/NF-κB signaling contributes to chronic unpredictable mild stress-induced atherosclerosis in ApoE-/- mice.
    Tang YL; Jiang JH; Wang S; Liu Z; Tang XQ; Peng J; Yang YZ; Gu HF
    PLoS One; 2015; 10(4):e0123685. PubMed ID: 25860573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of Vangl2 attenuates the inflammation promoted by Wnt5a via MAPK and NF-κB pathway in chondrocytes.
    Zhang K; Li Z; Lu Y; Xiang L; Sun J; Zhang H
    J Orthop Surg Res; 2021 Feb; 16(1):136. PubMed ID: 33588909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZeXieYin formula alleviates atherosclerosis by inhibiting the MAPK/NF-κB signaling pathway in APOE-/- mice to attenuate vascular inflammation and increase plaque stability.
    Huang R; Sun Y; Liu R; Zhu B; Zhang H; Wu H
    J Ethnopharmacol; 2024 Jun; 327():117969. PubMed ID: 38437888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The feedback loop of "EMMPRIN/NF-κB" worsens atherosclerotic plaque via suppressing autophagy in macrophage.
    Liang X; Hou X; Yang Y; Liu H; Guo R; Yang Z; Yang L
    J Mol Cell Cardiol; 2018 Jan; 114():129-140. PubMed ID: 29154780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baicalin alleviates atherosclerosis by relieving oxidative stress and inflammatory responses via inactivating the NF-κB and p38 MAPK signaling pathways.
    Wu Y; Wang F; Fan L; Zhang W; Wang T; Du Y; Bai X
    Biomed Pharmacother; 2018 Jan; 97():1673-1679. PubMed ID: 29793330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.
    Borst O; Schaub M; Walker B; Schmid E; Münzer P; Voelkl J; Alesutan I; Rodríguez JM; Vogel S; Schoenberger T; Metzger K; Rath D; Umbach A; Kuhl D; Müller II; Seizer P; Geisler T; Gawaz M; Lang F
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):547-57. PubMed ID: 25614279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effect of coptisine on experimental atherosclerosis ApoE
    Feng M; Kong SZ; Wang ZX; He K; Zou ZY; Hu YR; Ma H; Li XG; Ye XL
    Biomed Pharmacother; 2017 Sep; 93():721-729. PubMed ID: 28700976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of Non-POU-domain-containing octamer-binding protein stabilizes atherosclerotic plaque in apolipoprotein E-knockout mice via NF-κB signaling pathway.
    Zhang K; Zhang F; Yang JM; Kong J; Meng X; Zhang M; Zhang C; Zhang Y
    Int J Cardiol; 2018 Jul; 263():96-103. PubMed ID: 29673854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corosolic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice by regulating the nuclear factor-κB signaling pathway and inhibiting monocyte chemoattractant protein-1 expression.
    Chen H; Yang J; Zhang Q; Chen LH; Wang Q
    Circ J; 2012; 76(4):995-1003. PubMed ID: 22293444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
    Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
    Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis.
    Hueso M; De Ramon L; Navarro E; Ripoll E; Cruzado JM; Grinyo JM; Torras J
    Atherosclerosis; 2016 Dec; 255():80-89. PubMed ID: 27835742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor.
    Sun H; Zhang X; Zhao L; Zhen X; Huang S; Wang S; He H; Liu Z; Xu N; Yang F; Qu Z; Ma Z; Zhang C; Zhang Y; Hu Q
    J Cell Mol Med; 2015 Apr; 19(4):836-49. PubMed ID: 25661015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panax notogingseng saponins suppress RAGE/MAPK signaling and NF-kappaB activation in apolipoprotein-E-deficient atherosclerosis-prone mice.
    Dou L; Lu Y; Shen T; Huang X; Man Y; Wang S; Li J
    Cell Physiol Biochem; 2012; 29(5-6):875-82. PubMed ID: 22613987
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Karunakaran D; Nguyen MA; Geoffrion M; Vreeken D; Lister Z; Cheng HS; Otte N; Essebier P; Wyatt H; Kandiah JW; Jung R; Alenghat FJ; Mompeon A; Lee R; Pan C; Gordon E; Rasheed A; Lusis AJ; Liu P; Matic LP; Hedin U; Fish JE; Guo L; Kolodgie F; Virmani R; van Gils JM; Rayner KJ
    Circulation; 2021 Jan; 143(2):163-177. PubMed ID: 33222501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference of myocyte enhancer factor 2A accelerates atherosclerosis in apolipoprotein E-deficient mice.
    Zhou WP; Zhang H; Zhao YX; Liu GQ; Zhang JY
    PLoS One; 2015; 10(3):e0121823. PubMed ID: 25793529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
    Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.